The cytokine storm and COVID-19

被引:1135
作者
Hu, Biying [1 ]
Huang, Shaoying [2 ]
Yin, Lianghong [1 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Clin Med Coll 1, Guangzhou 510632, Peoples R China
[2] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Shenzhen, Peoples R China
关键词
COVID-19; cytokine storm; literature review; SARS-CoV-2; RESPIRATORY SYNDROME CORONAVIRUS; INFLAMMATORY CYTOKINES; DRUG DISCOVERY; CHLOROQUINE; INFECTIONS; CHEMOKINES; SARS;
D O I
10.1002/jmv.26232
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Coronavirus disease 2019 (COVID-19), which began in Wuhan, China, in December 2019, has caused a large global pandemic and poses a serious threat to public health. More than 4 million cases of COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been confirmed as of 11 May 2020. SARS-CoV-2 is a highly pathogenic and transmissible coronavirus that primarily spreads through respiratory droplets and close contact. A growing body of clinical data suggests that a cytokine storm is associated with COVID-19 severity and is also a crucial cause of death from COVID-19. In the absence of antivirals and vaccines for COVID-19, there is an urgent need to understand the cytokine storm in COVID-19. Here, we have reviewed the current understanding of the features of SARS-CoV-2 and the pathological features, pathophysiological mechanisms, and treatments of the cytokine storm induced by COVID-19. In addition, we suggest that the identification and treatment of the cytokine storm are important components for rescuing patients with severe COVID-19.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 81 条
[1]
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases [J].
Al-Bari, Md. Abdul Alim .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) :1608-1621
[2]
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review [J].
Alijotas-Reig, Jaume ;
Esteve-Valverde, Enrique ;
Belizna, Cristina ;
Selva-O'Callaghan, Albert ;
Pardos-Gea, Josep ;
Quintana, Angela ;
Mekinian, Arsene ;
Anunciacion-Llunell, Ariadna ;
Miro-Mur, Francesc .
AUTOIMMUNITY REVIEWS, 2020, 19 (07)
[3]
[Anonymous], IMMUNITY, DOI DOI 10.1016/J.JHIN.2020.04.003
[4]
[Anonymous], 2020, NIH COVID 19 TREATME
[5]
[Anonymous], 2020, ACR GUIDANCE PATIENT
[6]
[Anonymous], 2020, EULAR GUIDANCE PATIE
[7]
[Anonymous], 2020, BSR GUIDANCE PATIENT
[8]
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study [J].
Arabi, Yaseen M. ;
Shalhoub, Sarah ;
Mandourah, Yasser ;
Al-Hameed, Fahad ;
Al-Omari, Awad ;
Al Qasim, Eman ;
Jose, Jesna ;
Alraddadi, Basem ;
Almotairi, Abdullah ;
Al Khatib, Kasim ;
Abdulmomen, Ahmed ;
Qushmaq, Ismael ;
Sindi, Anees A. ;
Mady, Ahmed ;
Solaiman, Othman ;
Al-Raddadi, Rajaa ;
Maghrabi, Khalid ;
Ragab, Ahmed ;
Al Mekhlafi, Ghaleb A. ;
Balkhy, Hanan H. ;
Al Harthy, Abdulrahman ;
Kharaba, Ayman ;
Gramish, Jawaher A. ;
Al-Aithan, Abdulsalam M. ;
Al-Dawood, Abdulaziz ;
Merson, Laura ;
Hayden, Frederick G. ;
Fowler, Robert .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (09) :1837-1844
[9]
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response [J].
Arnaldez, Fernanda, I ;
O'Day, Steven J. ;
Drake, Charles G. ;
Fox, Bernard A. ;
Fu, Bingqing ;
Urba, Walter J. ;
Montesarchio, Vincenzo ;
Weber, Jeffrey S. ;
Wei, Haiming ;
Wigginton, Jon M. ;
Ascierto, Paolo Antonio .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[10]
Australian Rheumatology Association, 2020, AUSTR RHEUMATOLOGY A